Article Information
vol. 31 no. 166
PubMed
Published By
Print ISSN
Online ISSN
History
- Received April 18, 2022
- Accepted June 9, 2022
- Published online October 19, 2022.
Copyright & Usage
Copyright ©The authors 2022 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Daniel Reynolds1,
- Jason P. Burnham2,
- Cristina Vazquez Guillamet2,
- Mikaela McCabe3,
- Valerie Yuenger3,
- Kevin Betthauser3,
- Scott T. Micek3 and
- Marin H. Kollef1⇑
- 1Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, MO, USA
- 2Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO, USA
- 3Dept of Pharmacy Practice, University of Health Sciences and Pharmacy, St. Louis, MO, USA
- Corresponding author: Marin H. Kollef (kollefm{at}wustl.edu)
Article usage
Altmetrics
Vol 31 Issue 166
Table of Contents
The threat of multidrug-resistant/extensively drug-resistant Gram-negative respiratory infections: another pandemic
Jump To
- Article
- Abstract
- Abstract
- Introduction
- Antibiotic resistant Gram-negative pulmonary infections: key organisms and their epidemiology
- Overview of main resistance mechanisms
- Impact of Gram-negative antibiotic-resistant pulmonary infection on outcomes
- Novel and pipeline antibiotics
- Monoclonal antibodies
- Bacteriophage therapy
- Oligonucleotides
- Role of stewardship in curbing MDR spread
- Conclusions
- Footnotes
- References
- Figures & Data
- Info & Metrics